|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/35258491/ Autoimmune liver disease J Pediatr Gastroenterol Nutr. 2022 Mar 8. Expression of IL-37 Correlates with Immune Cell Infiltrate and Fibrosis in Pediatric Autoimmune Liver Diseases Lucas Griessmair 1 2, Laura Pirringer 1, Steffeni Mountford 1, Andrea Sendelhofert 3, Marie-Christine Makeschin 3, Sibylle Koletzko 1, Doris Mayr 3, Philip Bufler 2 Published on:
Mar-2022
|
https://pubmed.ncbi.nlm.nih.gov/35148883/ transplant Transplant Proc. 2022 Feb 8;S0041-1345(22)00063-X. Long-Term Outcome of Portal Vein Stenting After Pediatric Living Donor Liver Transplantation Takehisa Ueno 1, Chiyoshi Toyama 2, Koichi Deguchi 2, Kazunori Masahata 2, Motonari Nomura 2, Miho Watanabe 2, Masafumi Kamiyama 2, Yuko Tazuke 2, Kazuhiko Bessho 3, Hiroomi Okuyama 2 Abstract Published on:
Feb-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/34620760/ J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):186-191. Can the Enhanced Liver Fibrosis Score Be Used to Diagnose Children With Liver Fibrosis? Iben Thusing 1, Steen Antonsen 2, Benjamin Søgaard Hoffmann-Petersen 1, Helene Marlies Rasmussen 1, Per Wittenhagen 1 Abstract Objectives: The noninvasive Enhanced Liver Fibrosis (ELF) score is used in adults with liver fibrosis as a diagnostic aid. The ELF score combines 3 serum markers of extracellular matrix remodeling and fibrogenesis: hyaluronic acid (HA), the N-terminal pro-peptide of collagen type III (PIIINP), and tissue inhibitor of metalloproteinase-1 (TIMP-1). We aimed to evaluate the clinical use of the ELF score in children. Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35133671/ NAFLD Hepatology. 2022 Feb 8. Randomized Placebo-Controlled Trial of Losartan for Pediatric Nonalcoholic Fatty Liver Disease Miriam B Vos 1, Mark L Van Natta 2, Niviann M Blondet 3, Srinivasan Dasarathy 4, Mark Fishbein 5, Paula Hertel 6, Ajay K Jain 7, Saul J Karpen 1, Joel E Lavine 8, Saeed Mohammad 5, Laura A Miriel 2, Jean P Molleston 9, Marialena Mouzaki 10, Arun Sanyal 11, Emily P Sharkey 2, Jeffrey B Schwimmer 12, James Tonascia 2, Laura A Wilson 2, Stavra A Xanthakos 10, NASH Clinical Research Network Abstract Published on:
Feb-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/34505750/ Covid-19 Telemedicine in monitoring pediatric LT patients before and during COVID-19 pandemic Mirac Musaoğlu 1, Muhammed Yuksel 1 2, Ozlem Mizikoglu 1, Cigdem Arikan 1 2 Abstract Background: The delivery of healthcare services by telemedicine decreases costs of traveling for patients, is less time-consuming, and most importantly permits the connection between highly skilled specialists and patients. However, whether the use of telemedicine (text messaging) for LT patients was affected by the COVID-19 pandemic is unknown. Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35132740/ Liver transplant Pediatr Transplant. 2022 Feb 7;e14240. Neurological impairment in children with acute liver failure following liver transplantation-A single-center experience Kentaro Ide 1 2, Hajime Uchida 3, Seisuke Sakamoto 3, Nao Nishimura 1, Satoshi Nakagawa 1, Tohru Kobayashi 2 4, Shuichi Ito 2, Mureo Kasahara 3 Abstract Background: Although overall survival of ALF has improved, neurological restoration after recovery from ALF may not always be satisfactory. The purpose of this study was to investigate the occurrence and possible causes of NI in children with ALF following LT. Published on:
Feb-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35149651/ Covid 19 J Pediatr Gastroenterol Nutr. 2022 Feb 10. Severe Hepatitis in Pediatric COVID-19 Swati Antala 1, Tamir Diamond, Larry K Kociolek, Amit A Shah, Catherine A Chapin Abstract Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35131781/ Wilson BMJ Case Rep. 2022 Feb 7;15(2):e246075. Hyperpigmented patch: an uncommon but early marker of Wilson's disease Lokesh Tiwari 1, Fadila 2, Arnab Ghorui 2 Abstract Wilson's disease in childhood could present with features ranging from asymptomatic liver disease to acute liver failure and cirrhosis. Neurological manifestations and psychiatric illness occur more commonly in adults and older children. Skin manifestation with Wilson's disease is not frequently reported in literature but could be an early diagnostic clincher. We present a child with hepatic Wilson's disease and skin hyperpigmentation. We aim to highlight the possible importance of skin lesions as an early marker of Wilson's disease. Published on:
Feb-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35149641/ Hepatitis C J Pediatr Gastroenterol Nutr. 2022 Feb 10. Ledipasvir-sofosbuvir in Adolescents with Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy Manal Hamdy El-Sayed 1, Fatma S Elsayed Ebeid, Abdel-Rahman Zekri, Benedetta Massetto, Kathryn Kersey, Fangqiu Zhang, Anuj Gaggar, Walaa Elsayed, Alaa El-Haddad Abstract Objectives: In children with hematological malignancies, chronic HCV infection has been associated with more rapid liver disease progression and higher risk of malignancy relapse due to chemotherapy interruption. We evaluated the safety and efficacy of ledipasvir-sofosbuvir for 12 weeks in these patients. Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35109890/ PFIC Orphanet J Rare Dis. 2022 Feb 2;17(1):32. Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study Claudia Mighiu 1, Sonia O'Hara 2, Enrico Ferri Grazzi 2, Karen F Murray 3, Jörn M Schattenberg 4, Emily Ventura 5, Melanie Karakaidos 5, Alison Taylor 6, Harpreet Brrang 6, Anil Dhawan 7, Jose Willemse 8, Alan Finnegan 9 Abstract Published on:
Feb-2022
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
